Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
97 studies found for:    "Craniopharyngioma"
Show Display Options
Rank Status Study
1 Active, not recruiting Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)
Condition: Craniopharyngioma
Intervention: Radiation: Protontherapy
2 Completed 1.5T Intraoperative MR Imaging in Craniopharyngiomas
Condition: Craniopharyngioma
Intervention: Other: Intraoperative imaging using 1.5T MRI
3 Unknown  Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma
Condition: Craniopharyngioma
Intervention: Procedure: Different surgical approach and techniques being used to treat three subtype of CP
4 Active, not recruiting A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
Condition: Craniopharyngioma
Interventions: Procedure: Radical Surgery or Limited Surgery;   Radiation: Proton Therapy
5 Recruiting A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
Condition: Craniopharyngioma
Interventions: Radiation: Proton Therapy;   Procedure: Surgery
6 Recruiting Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
Condition: Childhood Craniopharyngioma
Interventions: Biological: peginterferon alfa-2b;   Other: laboratory biomarker analysis
7 Recruiting Prospective Study of Children and Adolescents With Craniopharyngioma
Conditions: Craniopharyngioma;   Obesity
Interventions: Radiation: Radiation;   Other: wait and watch
8 Not yet recruiting Multicentre Double-blind Randomized Clinical Trial Assessing Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
Conditions: Craniopharyngiomas;   Hypothalamic Obesity
Interventions: Drug: Exenatide;   Drug: Placebo
9 Completed Weight Gain in Surgically Treated Adult-onset Craniopharyngioma
Conditions: Adult-onset Craniopharyngioma;   Postoperative Weight Gain
Intervention:
10 Active, not recruiting Sleep Wake and Melatonin Pattern in Craniopharyngioma
Conditions: Sleep Disorders, Circadian Rhythm;   Craniopharyngioma
Intervention:
11 Completed
Has Results
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Conditions: Obesity;   Overweight;   Craniopharyngioma
Intervention: Drug: Exenatide
12 Completed Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy
Condition: Hypothalamic Obesity
Interventions: Drug: Diazoxide;   Drug: Metformin
13 Recruiting Intranasal Oxytocin in Hypothalamic Obesity
Conditions: Craniopharyngioma;   Hypothalamic Obesity
Interventions: Drug: Syntocinon;   Drug: Placebo (for Syntocinon)
14 Completed Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
Conditions: Brain and Central Nervous System Tumors;   Long-term Effects Secondary to Cancer Therapy in Children;   Perioperative/Postoperative Complications;   Psychosocial Effects of Cancer and Its Treatment;   Weight Changes
Interventions: Other: metabolic assessment;   Other: physiologic testing;   Procedure: biopsy;   Procedure: computed tomography;   Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: management of therapy complications;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
15 Completed Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
Conditions: Hypothalamic-pituitary Lesions;   Craniopharyngiomas
Intervention: Drug: DIAZOXIDE
16 Unknown  Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Conditions: Pituitary Neoplasms;   Craniopharyngiomas
Interventions: Drug: Hydrocortisone;   Drug: Prednisone
17 Completed An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury
Conditions: Obesity;   Over-weight;   Hypothalamic Injury;   Craniopharyngioma
Interventions: Drug: ZGN-440 sterile diluent;   Drug: ZGN-440 for injectable suspension
18 Active, not recruiting SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors
Conditions: Low Grade Gliomas;   Craniopharyngioma;   Ependymomas;   Meningiomas
Interventions: Radiation: Stereotactic Conformal radiotherapy;   Radiation: Conventional radiotherapy
19 Recruiting Energy Balance in Craniopharyngioma-related Hypothalamic Obesity
Condition: Hypothalamic Obesity
Interventions: Drug: Exenatide;   Drug: placebo
20 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.